Designed to dissolve under the tongue, sublingual semaglutide offers several advantages: Ease of Use : No needles or syringes are required, making it a comfortable option for those with a fear of injections or limited mobility
"And finally
This non-toxic profile distinguishes it from many other biologically active compounds and supports its favorable safety record
After 3 months of semaglutide, the percentage of patients with EE decreased from 72.5 to 11.5%, the percentage of patients with external eating decreased from 27.5 to 10.1%, the percentage of patients with craving decreased from 49.3 to 21.7%, and the percentage of patients with savory craving decreased from 53.6 to 14.5% [59]
[Read More] Svensson J, Lall S, Dickson SL, Bengtsson BA, Rmer J, Ahnfelt-Rnne I, Ohlsson C, Jansson JO